Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy-Reference-Cited by-同舟云学术

Non-risk-adapted surveillance for patients with stage I nonseminomatous testicular germ-cell tumors: diminishing treatment-related morbidity while maintaining efficacy

Published:2010-06 Issue:6 Volume:21 Page:1296-1301
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Kollmannsberger C.,Moore C.,Chi K.N.,Murray N.,Daneshmand S.,Gleave M.,Hayes-Lattin B.,Nichols C.R.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/21/6/1296/445917/mdp473.pdf

Reference30 articles.

1. The changing distribution of stage in nonseminomatous testicular germ cell tumours, from 1977 to 1996;Sonneveld;BJU Int,1999

2. The changing presentation of germ cell tumours of the testis between 1983 and 2002;Powles;BJU Int,2005

3. Medical Research Council prospective study of surveillance for stage I testicular teratoma. Medical Research Council Testicular Tumors Working Party;Read;J Clin Oncol,1992

4. A comprehensive systematic review of testicular germ cell tumor surveillance;Groll;Crit Rev Oncol Hematol,2007

5. Predictors of occult metastasis in clinical stage I nonseminoma: a systematic review;Vergouwe;J Clin Oncol,2003

Cited by 116 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Favorable long-term Health Related Quality of Life in cured survivors of testicular cancer management. So, what now?;Annals of Oncology;2023-12

2. Excellent Outcomes in Children, Adolescents, and Young Adults with Ovarian Germ Cell Tumors Treated by Either Reduced- or Standard-Dose Bleomycin;Cancers;2023-11-04

3. Testicular Seminoma in Prostate: Case Report and Review of Literature;Clinical Genitourinary Cancer;2023-11

4. H&E and OCT4/CD34 for the assessment of lympho-vascular invasion in seminoma and embryonal carcinoma;Pathology - Research and Practice;2023-02

5. Surveillance after Complete Response to First-Line Chemotherapy in Patients with Metastatic Nonseminomatous Germ Cell Tumor;Journal of Urology;2022-09